HELLP syndrome is characterized by hemolysis, elevated liver enzymes and thrombocytopenia. With a incidence of 0.1%-0.8% it is known to be effected by genetic predisposition. Unlike preeclempsia multiparity increases the risk of HELLP syndrome. Diagnosis is made by the classic clinical triad. Thrombocyte counts are especially important for classification of the disease. When making a diagnosis, severe preeclempsia, acute fatty liver of pregnancy, hemolytic ureamic syndrome and thrombocytopenic thrombotic purpura should be always be kept in mind for differential diagnosis. HELLP syndrome has several complications , including but not limited to; disseminated intravascular coagulopathy, acute renal failure, pulmonary edema, liver rupture and hematoma and retinal detachment. Suggested treatment modality consists, stabilization of blood pressure and magnesium sulfate infusion. Then evaluation of fetal status and planning delivery method and time if maternal status remains unstable. If prognosis seems favorable without urgent delivery and fetus can benefit from it, a course of betamethasone can be given to fetuses between 24 and 34 weeks of gestational age. The only and definite treatment of HELLP syndrome is delivering the baby. Suggested benefits of steroid therapy and other experimental treatments are still to be proven effective by large randomized controlled trials.
Alan : Sağlık Bilimleri
Dergi Türü : Ulusal
Benzer Makaleler | Yazar | # |
---|
Makale | Yazar | # |
---|